Sarepta therapeutics Contact Number

All Time Past 24 Hours Past Week Past month Post Your Comments?

Related Search

Listing Results Sarepta therapeutics Contact Number

Contact Us Sarepta Therapeutics

3 hours ago Sarepta.com Show details

617.274.4000General Inquiries617.274.4000 Sarepta Therapeutics Headquarters 215 First Street Cambridge, MA 02142 Patients and Families SareptAssist Patient Support888.727.3782 Contact SareptAssist for inquiries related to Sarepta's U.S. FDA-approved therapies for Duchenne, questions about continuation of therapy, and insurance and reimbursement matters.

Category: Sarepta phone numberShow more

Contact Us Sarepta Therapeutics

4 hours ago Sareptatherapeutics.ch Show details

Sarepta Therapeutics 215 First Street Cambridge, MA 02142 General Inquiries. For career, investor and media inquiries, please visit Sarepta Therapeutics' global website. Contact Form. If you have any questions or comments relative to our business, complete this form to contact us.

Category: Contact SupportShow more

Sarepta Therapeutics Crunchbase Company Profile & …

Just Now Crunchbase.com Show details

Number of Exits 1. Contact Email sarepta@sareptatherapeutics.com. Phone Number 5417543545. Sarepta Therapeutics is a biopharmaceutical company that focuses on the discovery and development of precision genetic medicine to treat rare diseases. It specializes in gene therapy, RNA-targeted exon skipping, and gene editing.

Founded: 1980
Founder: Marwan Fawaz

Category: Contact NumberShow more

Sarepta Therapeutics, Inc. Company Profile Cambridge, …

8 hours ago Dnb.com Show details

Find company research, competitor information, contact details & financial data for Sarepta Therapeutics, Inc. of Cambridge, MA. Get the latest business insights from Dun & Bradstreet.

Employees: 255
Tangible Fixed Assets: $282.19
Intangible Assets: $13.63
Location: 215 1ST St Ste 415, Cambridge, 02142-1213, MA

Category: Contact NumberShow more

Sarepta Therapeutics Company Profile Burlington, MA

4 hours ago Dnb.com Show details

(781) 221-7805Company Description: Sarepta Therapeutics is located in Burlington, MA, United States and is part of the Pharmaceutical and Medicine Manufacturing Industry. Sarepta Therapeutics has 15 total employees across all of its locations and generates $674,994 in sales (USD). (Employees and …

Employees: 2
Phone: (781) 221-7805
Location: 55 Network Dr, Burlington, 01803-2765, MA

Category: Contact NumberShow more

Sarepta Therapeutics Biopharmaceutical Company for …

4 hours ago Sarepta.com Show details

Sarepta is engineering solutions for rare diseases with science that is on the forefront of precision genetic medicine. Our platforms include: gene therapy, RNA technologies, and gene editing. We are in a daily race to save lives stolen or impacted by rare disease. Patients can’t wait for the next breakthrough in medical research.

Category: Contact NumberShow more

Sarepta Therapeutics other Contacts Business Emails, Phone

5 hours ago Adapt.io Show details

Find the Sarepta Therapeutics company's other team/department contact details such as business emails, phone numbers, web address and other details. Get access to 100M+ contacts on Adapt.io.

Category: Phone Number, Contact SupportShow more

Sarepta Therapeutics Opens Genetic Therapies Center of

8 hours ago Globenewswire.com Show details

617-274-4052About Sarepta Therapeutics our plans to double the number of employees in Columbus, Source: Sarepta Therapeutics, Inc. Investor Contact: Ian Estepan, 617-274-4052

Category: Contact NumberShow more

EIN 930797222 Sarepta Therapeutics, Inc., Cambridge

8 hours ago Eintaxid.com Show details

Sarepta Therapeutics, Inc. is a corporation in Cambridge, Massachusetts. The employer identification number (EIN) for Sarepta Therapeutics, Inc. is 930797222. EIN for organizations is sometimes also referred to as taxpayer identification number or TIN or simply IRS Number. It is one of the corporates which submit 10-K filings with the SEC.

Category: Contact NumberShow more

CLINICAL STUDY PROTOCOL

7 hours ago Clinicaltrials.gov Show details

Sarepta Therapeutics, Inc. Study 4658-204 Page 4 of 55 FINAL 05 JULY 2016 PROCEDURES IN CASE OF EMERGENCY Table 1: Emergency Contact Information Role in Study Name Address and Telephone number Responsible Physician , MD, PhD Sarepta Therapeutics, Inc. 215 First Street Cambridge, MA 02142 Telephone: Mobile: PPD PPD PPD PPD

Category: Contact NumberShow more

EX3.1

2 hours ago Sec.gov Show details

NUMBER OF DIRECTORS. 10 : Section 3.03 : ELECTION, QUALIFICATION AND TERM OF OFFICE OF DIRECTORS. SAREPTA THERAPEUTICS, INC. The Corporation shall not be required to include electronic mail addresses or other electronic contact information on such list. Such list shall be open to the examination of any stockholder, for any purpose

Category: Contact NumberShow more

Sarepta Therapeutics Opens Genetic Therapies Center of

5 hours ago Investorrelations.sarepta.com Show details

617-274-4052Source: Sarepta Therapeutics, Inc. Investor Contact: Ian Estepan, 617-274-4052 [email protected]sarepta.com. Media Contact: Tracy Sorrentino, 617-301-8566 [email protected]sarepta.com. Multimedia. Sarepta’s Genetic Therapies Center of Excellence – Building Exterior; Grand Opening Ceremony (Oct 4, 2021) Photos accompanying this announcement are available at

Category: Contact NumberShow more

Sarepta Therapeutics Biopharmaceutical Company for Rare

8 hours ago Sareptatherapeutics.co.uk Show details

44 121 468Medical Information Inquiries only +44 121 468 0917 [email protected]sarepta.com General Enquiries. For career, investor and media enquiries, please visit Sarepta Therapeutics' global website. Contact Form. If you have any questions or comments relative to our business, complete this form to contact us.

Category: Contact NumberShow more

Sarepta Therapeutics Overview, News & Competitors

7 hours ago Zoominfo.com Show details

(617) 274-4000Sarepta Therapeutics’s headquarters are in 215 First Street, Cambridge, Massachusetts, 02142, United States. What is Sarepta Therapeutics’s phone number? Sarepta Therapeutics’s phone number is (617) 274-4000. What is Sarepta Therapeutics’s stock …

Category: Contact NumberShow more

Sarepta Therapeutics Opens Genetic Therapies Center of

Just Now Finance.yahoo.com Show details

617-274-4052About Sarepta Therapeutics our plans to double the number of employees in Columbus, Source: Sarepta Therapeutics, Inc. Investor Contact: Ian Estepan, 617-274-4052

1. Author: Sarepta Therapeutics, Inc.

Category: Contact NumberShow more

FAQs Sarepta Therapeutics, Inc.

2 hours ago Investorrelations.sarepta.com Show details

617.274.4000The company was subsequently renamed Sarepta Therapeutics, Inc. in 2012. Where is Sarepta's corporate headquarters? Sarepta’s principal executive offices are located at 215 First Street, Cambridge, MA 02142. Our main phone number is 617.274.4000. Who are the members of Sarepta's Board of Directors? Additional contact information

Category: Contact NumberShow more

Sarepta Therapeutics, Inc. (SRPT) Company Profile & Facts

4 hours ago Finance.yahoo.com Show details

See the company profile for Sarepta Therapeutics, Inc. (SRPT) including business summary, industry/sector information, number of employees, business summary, corporate governance, key …

Category: Contact NumberShow more

Zacks: Analysts Expect Sarepta Therapeutics, Inc. (NASDAQ

1 hours ago Marketbeat.com Show details

Wall Street analysts expect Sarepta Therapeutics, Inc. (NASDAQ:SRPT) to report $192.62 million in sales for the current quarter, according to Zacks Investment Research. Five analysts have made estimates for Sarepta Therapeutics' earnings. The highest sales estimate is …

Category: Contact NumberShow more

Sarepta Therapeutics (NASDAQ:SRPT) Lifted to Overweight at

6 hours ago Marketbeat.com Show details

Sarepta Therapeutics (NASDAQ:SRPT) was upgraded by research analysts at JPMorgan Chase & Co. from a "neutral" rating to an "overweight" rating in a research note issued to investors on Friday, The Fly reports. A number of other equities analysts also recently issued reports on SRPT. Credit Suisse Group lifted their price objective on shares of Sarepta Therapeutics from …

Category: Contact NumberShow more

Sarepta Therapeutics Funding, Financials, Valuation

9 hours ago Crunchbase.com Show details

Sarepta Therapeutics has raised a total of $1.4B in funding over 6 rounds. Their latest funding was raised on Oct 13, 2021 from a Post-IPO Equity round. Sarepta Therapeutics is registered under the ticker NASDAQ:SRPT . Their stock opened with $9.00 in its Jun 4, 1997 IPO. Sarepta Therapeutics is funded by 3 investors.

Category: Contact NumberShow more

1. Sarepta Therapeutics FiercePharma

6 hours ago Fiercepharma.com Show details

1. Sarepta Therapeutics 2018 median employee pay: $329,229 2018 number of employees: 499 CEO: Douglas Ingram 2018 CEO pay: $1.43 million CEO-to-employee pay ratio: 4.4:1

Category: Contact NumberShow more

Sarepta Therapeutics, Inc. (SRPT) Company Profile

6 hours ago Stockanalysis.com Show details

Company profile for Sarepta Therapeutics, Inc. (SRPT) with a description, list of executives, contact details and other key facts. Company profile for Sarepta Therapeutics, Inc. (SRPT) with a description, list of executives, contact details and other key facts. CUSIP Number: 002346104: ISIN Number: US8036071004: Employer ID: 93-0797222: Key

Category: Contact NumberShow more

Analyst Ratings For Sarepta Therapeutics Markets Insider

9 hours ago Markets.businessinsider.com Show details

These 6 analysts have an average price target of $118.67 versus the current price of Sarepta Therapeutics at $90.18, implying upside. Below is a summary of how these 6 …

Category: Contact NumberShow more

Participate in a Clinical Trial Sarepta Therapeutics

5 hours ago Clinicaltrials.sarepta.com Show details

A clinical trial—a critical part of developing a new drug, biologic, or medical device—is a research study conducted in human participants to test a potential treatment for safety, efficacy, dosing, and more. Regulatory authorities use trial data and other information to …

Category: Contact NumberShow more

Sarepta Therapeutics (SRPT) Q3 2021 Earnings Call

1 hours ago Nasdaq.com Show details

021-11-04Operator. Good afternoon, ladies and gentlemen and welcome to the Sarepta Therapeutics third quarter 2021 earnings call. [Operator instructions] As …

Category: Contact NumberShow more

Sarepta Therapeutics: Number of Employees 20062021 SRPT

7 hours ago Macrotrends.net Show details

Interactive chart of Sarepta Therapeutics (SRPT) annual worldwide employee count from 2006 to 2021. Sarepta Therapeutics total number of employees in 2020 was 866, a 16.55% increase from 2019.; Sarepta Therapeutics total number of employees in 2019 was 743, a 48.9% increase from 2018.; Sarepta Therapeutics total number of employees in 2018 was 499, a 95.69% increase from 2017.

Category: Contact NumberShow more

Sarepta Therapeutics (SRPT) Q3 2021 Earnings Call Transcript

1 hours ago Msn.com Show details

Total net product revenue for the quarter of 2021 from our PMO exon skipping franchise was $166.9 million, compared to $121.4 million for the same period of 2020. For the third quarter of 2021

Category: Contact NumberShow more

Sarepta Therapeutics Wikipedia

Just Now En.wikipedia.org Show details

Sarepta Therapeutics, Inc. (Nasdaq: SRPT) is a medical research and drug development company with corporate offices and research facilities in Cambridge, Massachusetts, United States.Incorporated in 1980 as AntiVirals, shortly before going public the company changed its name from AntiVirals to AVI BioPharma soon with stock symbol AVII and in July 2012 changed name from AVI BioPharma to …

Category: Contact NumberShow more

Sarepta Therapeutics Announces Third Quarter 2021

4 hours ago Biospace.com Show details

Sarepta Therapeutics Announces Third Quarter 2021 Financial Results and Recent Corporate Developments Published: Nov 03, 2021 Net product sales for the third quarter of 2021 reached $166.9 million, a 37% increase over the same quarter of prior year

Category: Contact NumberShow more

Is Sarepta Therapeutics Inc (SRPT) a Leader in the

8 hours ago Investorsobserver.com Show details

Sarepta Therapeutics Inc (SRPT) stock has risen 1.24% while the S&P 500 is down -2.02% as of 2:00 PM on Tuesday, Sep 28. SRPT is up $1.13 from the previous closing price of $91.08 on volume of 456,120 shares. Over the past year the S&P 500 is higher by 29.88% while SRPT is down -35.61%. SRPT lost -$8.03 per share the over the last 12 months.

Category: Contact NumberShow more

A Gene Transfer Therapy Study to Evaluate the Safety and

7 hours ago Clinicaltrials.gov Show details

001-301 2019Sarepta Therapeutics, Inc. ClinicalTrials.gov Identifier: NCT05096221 Other Study ID Numbers: SRP-9001-301 2019-003374-91 ( EudraCT Number ) First Posted: October 27, 2021 Key Record Dates: Last Update Posted: November 4, 2021 Last Verified: October 2021

Category: Contact NumberShow more

Sarepta Therapeutics Email Format sarepta.com Emails

3 hours ago Rocketreach.co Show details

Sarepta Therapeutics Email Format. Sarepta Therapeutics uses 2 email formats, with first_initial last (ex. [email protected]sarepta.com) being used 99.0% of the time. Get Verified Emails for Sarepta Therapeutics Employees. Sarepta Therapeutics's Email Format.

Category: Contact NumberShow more

Sarepta Therapeutics (SRPT) Reports Q3 Loss, Tops Revenue

5 hours ago Zacks.com Show details

Sarepta Therapeutics (SRPT) delivered earnings and revenue surprises of 67.74% and 11.33%, respectively, for the quarter ended September 2021. Do …

Category: Contact NumberShow more

Why Sarepta Therapeutics Tumbled Today The Motley Fool

1 hours ago Fool.com Show details

Why Sarepta Therapeutics Fell 14.7% This Week Sarepta Therapeutics (SRPT) Q2 2021 Earnings Call Transcript Why Sarepta's Q1 Results Won't Spark a …

Category: Contact NumberShow more

Sarepta Therapeutics Inc. (NASDAQ:SRPT) Has Reached A

3 hours ago Marketingsentinel.com Show details

Investors also watch the number of corporate investors in a company very closely, which is 83.60% institutions for Sarepta Therapeutics Inc. that are currently holding shares of the company. Capital Research Global Investors is the top institutional holder at SRPT for having 8.03 million shares of worth $598.25 million.

Category: Contact NumberShow more

Sarepta Therapeutics, Inc. (SRPT) CEO Doug Ingram on Q3

Just Now Seekingalpha.com Show details

Sarepta Therapeutics, Inc. (NASDAQ:SRPT) Q3 2021 Earnings Conference Call November 3, 2021 16:30 ET Company Participants Mary Jenkins - Senior Manager of …

Category: Contact NumberShow more

Jessica Xu Executive Director, Accounting Sarepta

4 hours ago Apollo.io Show details

617-274-4000Jessica Xu's Professional Contact Details. Email (Verified) j**@sarepta.com. Get Email Address. Mobile Number. (XXX) XXX-XXXX. Get Mobile Number. HQ. +1 617-274-4000.

Category: Contact NumberShow more

Sarepta Therapeutics Reviews Glassdoor

4 hours ago Glassdoor.com Show details

Sarepta is a patient-centric company with a highly collaborative culture, working on cutting-edge exon skipping, gene therapy and gene editing technologies. It is a very dynamic and exciting place to work, and leadership sincerely cares about their employees.

Category: Contact NumberShow more

5 Stocks Cathie Wood is Selling Insider Monkey

1 hours ago Insidermonkey.com Show details

Number of Hedge Fund Holders: 34 . Sarepta Therapeutics, Inc. (NASDAQ:SRPT) is a commercial-stage biotech firm. It focuses on the development of therapies for the treatment of …

Category: Contact NumberShow more

Is Sarepta Therapeutics Worthy of Redemption? The Motley

7 hours ago Fool.com Show details

1. DMD is a degenerative disease characterized by progressive muscle weakness that primarily affects young boys, with onset often taking place between three to six years of age. With 16,840 patients in the U.S., DMD is a rare disease, and clinical trial test subjects are relatively difficult to obtain. While no curative treatment exists, the U.S. Food and Drug Administration (FDA) has approved various treatments, including three of Sarepta's. While those drugs (eteplirsen, golodirsen, and casimersen) work on RNA, SRP-9001 works on DNA.

Category: Contact NumberShow more

Sarepta Therapeutics to Initiate Part B of MOMENTUM Study

6 hours ago Apnews.com Show details

617-274-4052Source: Sarepta Therapeutics, Inc. Investor Contact: Ian Estepan, 617-274-4052 [email protected]sarepta.com Media Contact: Tracy Sorrentino, 617-301-8566 [email protected]sarepta.com

Category: Contact NumberShow more

SRPT Sarepta Therapeutics Inc. • BioPharmCatalyst

5 hours ago Biopharmcatalyst.com Show details

617-274-4052Source: Sarepta Therapeutics, Inc. Investor Contact: Ian Estepan, 617-274-4052 certain programs may never advance in the clinic or may be discontinued for a number of reasons, including regulators imposing a clinical hold and us suspending or terminating clinical research or trials; if the actual number of patients suffering from the

Category: Contact NumberShow more

Top Sarepta Therapeutics Competitors and Alternatives

3 hours ago Craft.co Show details

Sarepta Therapeutics's top competitors include Ionis Pharmaceuticals, Moderna, Intarcia Therapeutics, CureVac, Alnylam Pharmaceuticals and Regulus Therapeutics. Add company You can compare up to 12 companies. Please remove a company to add a new one. Sarepta Therapeutics is a biopharmaceutical company focused on developing innovative RNA

Category: Contact NumberShow more

Expert Ratings For Sarepta Therapeutics Sarepta

5 hours ago Benzinga.com Show details

In the last 3 months, 6 analysts have offered 12-month price targets for Sarepta Therapeutics. The company has an average price target of $95.33 with a high of $125.00 and a …

Category: Contact NumberShow more

2021 Global Duchenne Muscular Dystrophy Landscape: Notable

2 hours ago Thedailytimes.com Show details

2021 Global Duchenne Muscular Dystrophy Landscape: Notable Providers Include Sarepta Therapeutics, Nippin Shinyaku and Pfizer - ResearchAndMarkets.com Oct 29, 2021 Oct 29, 2021 Updated Oct 29, 2021

Category: Contact NumberShow more

Brian Burrows Manager, Talent Acquisition Sarepta

7 hours ago Apollo.io Show details

Sarepta Therapeutics is a biopharmaceutical company that focuses on the discovery and development of precision genetic medicine to treat rare diseases. It specializes in gene therapy, RNA-targeted exon skipping, and gene editing.It was founded in 1980 and headquartered in Cambridge, Massachusetts.

Category: Contact NumberShow more

(CDAK), Sarepta Therapeutics, Inc. (NASDAQ:SRPT) Sarepta

7 hours ago Benzinga.com Show details

Sarepta Therapeutics Inc (NASDAQ: SRPT) notified Codiak BioSciences Inc (NASDAQ: CDAK) that it would terminate the two-year Research License and Option agreement early.; The termination will be

Category: Contact NumberShow more

All Time Past 24 Hours Past Week Past month

Please leave your comments here:

Brand New Updated

Frequently Asked Questions

Where are the headquarters of Sarepta Therapeutics Inc?

Sarepta Therapeutics Inc. (NASDAQ: SRPT) is a medical research and drug development company with corporate offices and research facilities in Cambridge, Massachusetts, United States.

How many patents does Sarepta Therapeutics have to date?

Sarepta Therapeutics Inc. (NASDAQ: SRPT) is a medical research and drug development company with corporate offices and research facilities in Cambridge, Massachusetts, United States. As of 2008, Sarepta has 170 issued medical patents, and over 150 patents pending.

When does Sarepta Therapeutics present at the World Muscle Society?

CAMBRIDGE, Mass., Sept. 14, 2021 (GLOBE NEWSWIRE) -- Sarepta Therapeutics, Inc. (NASDAQ:SRPT), the leader in precision genetic medicine for rare diseases, will present at the World Muscle Society 2021 Virtual Congress (WMS 2021), taking place Sept. 20-24, 2021.

What kind of diseases does Sarepta Therapeutics treat?

Sarepta is at the forefront of precision genetic medicine, having built an impressive and competitive position in Duchenne muscular dystrophy (DMD) and more recently in gene therapies for 5 Limb-girdle muscular dystrophy diseases (LGMD), Charcot-Marie-Tooth (CMT), MPS IIIA, Pompe and other CNS-related disorders,...

Popular Brands

Sharp
Shell
Sap
Sgs
Sabb
Sea